To hear about similar clinical trials, please enter your email below

Trial Title: Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia

NCT ID: NCT05977062

Condition: Cancer
Insomnia

Conditions: Official terms:
Sleep Initiation and Maintenance Disorders

Study type: Interventional

Study phase: N/A

Overall status: Active, not recruiting

Study design:

Allocation: N/A

Intervention model: Single Group Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Other
Intervention name: Self screening
Description: Score ISI (Index de Sévérité de l'Insomnie)
Arm group label: Coaching arm

Intervention type: Other
Intervention name: Phone call
Description: Phone call at the beginning of the program and at the middle and at the end.
Arm group label: Coaching arm

Intervention type: Other
Intervention name: Online questionnaires
Description: To be completed at week 1, 6, 12 and 24.
Arm group label: Coaching arm

Summary: Determine who can benefit from additional follow-up by a professional and what type of help is most appropriate (need and expectation of patients in terms of support by a health professional)

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Adults patients, - With a diagnosis of localized or metastatic cancer, - During or after their treatment, - In one of the following three cancer centres: Gustave Roussy (Villejuif), Montpellier Cancer Institute (Montpellier), and Léon Bérard Center (Lyon) - With a significative score on the self-screening Insomnia Severity Index score (ISI ≥ 8) - Able to readily read and understand French, - Able to use informatic tools confidently and with Internet access, - Who have signed the online consent form, - Affiliated to a social security system or beneficiary of the same. Exclusion Criteria: - Patient with a visual, hearing or cognitive disability that is incompatible with the study, - Simultaneous participation in another study evaluating a treatment of insomnia, - Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Centre Léon Bérard

Address:
City: Lyon
Zip: 69008
Country: France

Facility:
Name: Institut de Cancérologie de Montpellier

Address:
City: Montpellier
Zip: 34090
Country: France

Facility:
Name: Gustave Roussy

Address:
City: Villejuif
Zip: 94805
Country: France

Start date: February 25, 2022

Completion date: October 13, 2024

Lead sponsor:
Agency: Gustave Roussy, Cancer Campus, Grand Paris
Agency class: Other

Source: Gustave Roussy, Cancer Campus, Grand Paris

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05977062

Login to your account

Did you forget your password?